BioCentury | Nov 7, 2013
Translation in Brief

Translational tidbits

...develop and verify biomarkers in areas such as narcotics and immunosuppressants AstraZeneca plc (LSE:AZN; NYSE:AZN) National Research Program for Biopharmaceuticals...
BioCentury | Oct 21, 2013
Company News

AstraZeneca, National Research Program for Biopharmaceuticals deal

...financial details, and the NRPB could not be reached. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. National Research Program for Biopharmaceuticals (NRPB)...
Items per page:
1 - 2 of 2
BioCentury | Nov 7, 2013
Translation in Brief

Translational tidbits

...develop and verify biomarkers in areas such as narcotics and immunosuppressants AstraZeneca plc (LSE:AZN; NYSE:AZN) National Research Program for Biopharmaceuticals...
BioCentury | Oct 21, 2013
Company News

AstraZeneca, National Research Program for Biopharmaceuticals deal

...financial details, and the NRPB could not be reached. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. National Research Program for Biopharmaceuticals (NRPB)...
Items per page:
1 - 2 of 2